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In the molecule of the title compound, C10H8ClNO2, the
indole ring system is planar. In the crystal structure, the
molecules are linked by intermolecular N—H  O hydrogen
bonds, forming centrosymmetric dimers.
Comment
The synthesis of indole derivatives has long been a topic of
fundamental interest to organic and medicinal chemists
(Murphy et al., 1997; Cavallini et al., 1958). Indole dervivatives
are important pharmacologically, possessing anti-allergic
(Shigenaga et al., 1993), central-nervous-system depressant
(Sen Gupta et al., 1982), muscle relaxant (Butera et al., 2001),
and anti-cancer (Al-Soud et al., 2004; Hu et al., 2005; Preo-
brazhenskaya et al., 1993) properties. The Fischer indole
synthesis is the most widely used method for the preparation
of indole derivatives (Robinson, 1982; Hughes, 1993). The
chemistry of indoles and their synthetic applications have
been published (Murakami, 1999). The crystal structure of
methyl indole-3-carboxylate has been reported (Hu et al.,
2005), as have the structures of some esters of indole-2-
carboxylic acid (Chandrakantha et al., 1990, 1992, 1998). In
view of the importance of the title compound, (I), its crystal
structure is reported here.
In the molecule of the title compound, (I) (Fig. 1), the bond
lengths and angles are in normal ranges (Allen et al., 1987;
Allen, 2002).
Figure 1
A drawing of the title molecular structure, with the atom-numbering
scheme. Displacement ellipsoids are drawn at the 20% probability level.
An examination of the deviations from the least-squares
planes through individual rings shows that rings A (N1/C2/C3/
C8/C9) and B (C4—C9) are each planar. The indole ring
system is planar, with a puckering amplitude QT = 0.021 (3) A˚
(Cremer & Pople, 1975). The dihedral angle between rings A
and B is 0.52 (3). The mean plane of the methoxy carbonyl
group subtends a dihedral angle of 3.43 (2) with respect to the
indole ring system.
As can be seen from the packing diagram (Fig. 2), inter-
molecular N—H  O hydrogen bonds (Table 1) link the
molecules, forming centrosymmetric dimers. Dipole-dipole
and van der Waals interactions are effective in the molecular
packing.
Experimental
The title compound was prepared following the reported procedure
(Narayana et al., 2005). Methylpyruvate-4-chlorophenylhydrazone
(2 g, 8.8 mmol) was taken up in polyphosphoric acid (PPA) (10 ml)
and continuously stirred. The reaction mass was slowly heated to 333–
343 K and maintained for 4 h. Progress of the reaction was monitored
by TLC. The reaction mass was cooled and added to water (100 ml),
forming a slurry. The separated solid was filtered and washed with
water. The dried crude product was purified with charcoal in ethyl
acetate at 323 K, filtered and slowly cooled to room temperature and
kept overnight with stirring. After one more recrystallization from
ethyl acetate, compound (I) was obtained as colorless crystals from an
acetone/toluene (8:2) mixture (yield 65%, m.p. 496 K).
Crystal data
C10H8ClNO2
Mr = 209.62
Monoclinic, P21=n
a = 12.786 (2) A˚
b = 4.0070 (7) A˚
c = 19.040 (3) A˚
 = 103.932 (2)
V = 946.7 (3) A˚3
Z = 4
Dx = 1.471 Mg m
3
Mo K radiation
 = 0.37 mm1
T = 273 (2) K
Needle, colorless
0.71  0.24  0.17 mm
Data collection
Bruker Apex2 CCD area-detector
diffractometer
’ and ! scans
Absorption correction: multi-scan
SADABS (Sheldrick, 1996)
Tmin = 0.778, Tmax = 0.939
8678 measured reflections
2321 independent reflections
1674 reflections with I > 2(I)
Rint = 0.026
max = 28.2

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.038
wR(F 2) = 0.118
S = 1.02
2321 reflections
128 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0559P)2
+ 0.2468P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.002
max = 0.21 e A˚
3
min = 0.28 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N1—H1A  O1i 0.86 2.03 2.8641 (19) 164
Symmetry code: (i) x þ 1;yþ 2;zþ 1.
H atoms were positioned geometrically, with N—H = 0.86 A˚, C—
H = 0.93 and 0.96 A˚ for aromatic and methyl H, respectively, and
constrained to ride on their parent atoms, with Uiso(H) = xUeq(C,N),
where x = 1.5 for methyl H, and x = 1.2 for all other H atoms.
Data collection: APEX2 (Bruker 2006); cell refinement: APEX2;
data reduction: APEX2; program(s) used to solve structure:
SHELXS97 (Sheldrick, 1997); program(s) used to refine structure:
SHELXL97 (Sheldrick, 1997); molecular graphics: SHELXTL
(Bruker 2000); software used to prepare material for publication:
SHELXTL.
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